Overexpression of splicing factor poly(rC)-binding protein 1 elicits cycle arrest, apoptosis induction, and p73 splicing in human cervical carcinoma cells

[1]  Kankan Wang,et al.  Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia , 2020, Neoplasia.

[2]  R. Reiter,et al.  Melatonin: A new inhibitor agent for cervical cancer treatment , 2019, Journal of cellular physiology.

[3]  D. Viñal,et al.  ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells) , 2019, Clinical and Translational Oncology.

[4]  X. Su,et al.  Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome1 , 2019, Neoplasia.

[5]  Hong Zhang,et al.  Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells , 2019, Artificial cells, nanomedicine, and biotechnology.

[6]  J. Hoheisel,et al.  Function, clinical application, and strategies of Pre-mRNA splicing in cancer , 2018, Cell Death & Differentiation.

[7]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[8]  R. Jia,et al.  Splicing factor poly(rC)‐binding protein 1 is a novel and distinctive tumor suppressor , 2018, Journal of cellular physiology.

[9]  Hui Li,et al.  PCBP1 depletion promotes tumorigenesis through attenuation of p27Kip1 mRNA stability and translation , 2018, Journal of Experimental & Clinical Cancer Research.

[10]  T. Ishii,et al.  Specific binding of PCBP1 to heavily oxidized RNA to induce cell death , 2018, Proceedings of the National Academy of Sciences.

[11]  Jun Chen,et al.  MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma , 2018, Journal of experimental & clinical cancer research : CR.

[12]  R. Barderas,et al.  Clinical implications of the deregulated TP73 isoforms expression in cancer , 2018, Clinical and Translational Oncology.

[13]  Yuanyu Wu,et al.  Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis , 2017, Scientific Reports.

[14]  D. Marzese,et al.  TP73 DNA methylation and upregulation of ΔNp73 are associated with an adverse prognosis in breast cancer , 2017, Journal of Clinical Pathology.

[15]  Xiaowu Li,et al.  Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1 , 2017, International journal of oncology.

[16]  D. Baralle,et al.  RNA splicing in human disease and in the clinic. , 2017, Clinical science.

[17]  Feng-Hou Gao,et al.  Role and molecular mechanism of heterogeneous nuclear ribonucleoprotein K in tumor development and progression. , 2016, Biomedical reports.

[18]  B. Liu,et al.  Poly C binding protein 1 represses autophagy through downregulation of LC3B to promote tumor cell apoptosis in starvation. , 2016, The international journal of biochemistry & cell biology.

[19]  A. Ganser,et al.  High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia. , 2015, Blood.

[20]  Hong Zhang,et al.  Diallyl disulfide attenuated carbon ion irradiation-induced apoptosis in mouse testis through changing the ratio of Tap73/ΔNp73 via mitochondrial pathway , 2015, Scientific Reports.

[21]  Meifeng Zhou,et al.  Downregulated Poly-C binding protein-1 is a novel predictor associated with poor prognosis in Acute Myeloid Leukemia , 2015, Diagnostic Pathology.

[22]  Yifei Liu,et al.  Expression of poly(C)-binding protein 1 (PCBP1) in NSCLC as a negative regulator of EMT and its clinical value. , 2015, International journal of clinical and experimental pathology.

[23]  H. Gautrey,et al.  Deregulation of splicing factors and breast cancer development. , 2015, Journal of molecular cell biology.

[24]  N. Ferrari,et al.  Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression. , 2014, Cancer letters.

[25]  P. Subramanian,et al.  Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2. , 2011, Cell metabolism.

[26]  P. Howe,et al.  Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles. , 2010, RNA.

[27]  J. Li,et al.  PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. , 2010, Cancer cell.

[28]  Liujun Tang,et al.  PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells , 2010, Molecular Cancer.

[29]  M. Levrero,et al.  The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting , 2009, Clinical Cancer Research.

[30]  I. Jurisica,et al.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. , 2008, Genes & development.

[31]  H. Loh,et al.  Novel function of the poly(C)‐binding protein αCP3 as a transcriptional repressor of the mu opioid receptor gene , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  C. Hartmann,et al.  MMP-13, p53 in the Progression of Malignant Peripheral Nerve Sheath Tumors , 2007 .

[33]  H. Ngan,et al.  Enhancement of the radiosensitivity of cervical cancer cells by overexpressing p73α , 2006, Molecular Cancer Therapeutics.

[34]  J. Lawler,et al.  Exercise training attenuates age‐induced elevation in Bax/Bcl‐2 ratio, apoptosis, and remodeling in the rat heart , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  G. Melino,et al.  TAp73/ΔNp73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma , 2005, Cell Death and Differentiation.

[36]  G. Melino,et al.  TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. , 2005, Cell death and differentiation.

[37]  A. Chkheidze,et al.  A Novel Set of Nuclear Localization Signals Determine Distributions of the αCP RNA-Binding Proteins , 2003, Molecular and Cellular Biology.

[38]  A. Antony,et al.  Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer , 2003, Journal of clinical pathology.

[39]  U. Moll,et al.  ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors , 2002, The Journal of experimental medicine.

[40]  G. Melino,et al.  p73: Friend or foe in tumorigenesis , 2002, Nature Reviews Cancer.

[41]  J. Eberle,et al.  The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. , 2001, The Journal of investigative dermatology.

[42]  H. Leffers,et al.  Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains. , 1996, European journal of biochemistry.

[43]  E. Smeland,et al.  Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K. , 1994, Nucleic Acids Research.